期刊文献+

基因变异功能学研究在不典型长QT综合征诊断中的作用

Functional study of a gene variant as an aid in diagnosis for patients with suspected long QT syndrome
原文传递
导出
摘要 目的探讨基因变异功能学研究在临床不典型长QT综合征(LQTS)诊断中的作用。方法先证者有晕厥事件,心电图无QTc延长,临床疑诊LQTS;基因检测显示KCNH2基因M756V变异;家系中变异携带者QT正常,无心脏事件。分别使用含有野生型(WT)和突变M756V HERG基因的pcDNA3.1重组质粒进行转染,设WT+M756V共转染组。转染后进行膜片钳和免疫组化研究明确临床诊断。结果 HERG M756V组电流较WT组明显减低,提示M756V变异为具有病理意义的LQTS突变;HERG M756V与WT共转染并无明显负显性机制。免疫组化研究表明HERG M756V蛋白存在转运障碍。结论体外功能学研究证实KCNH2基因M756V变异为LQTS突变,为临床疑诊患者提供确诊依据。 Objective To evaluate the value of functional study of a gene variant in diagnosis for patients with suspected long QT syndrome (LQTS). Methods The KCNI-I2 mutation M756V was engineered into wild-type (WT) eDNA cloned in pcDNA3.1 plasmid. Patch clamp and immunostaining were performed 48 hours later after transient transfeetion. Results Patch clamp study showed that KCNI-I2 M756V was loss of function compared with WT channel and confirmed that KCNH2 M756V was a mutation of LQTS. KCNH2 M756V did not produce a dominant negative effect on WT channel. Immunostaining showed that KCNH2 M756V protein had a trafficking defect. Conclusions In vitro functional study demonstrates that KCNH2 M756V variant identified in patients with suspected LQTS is a LQTS mutation, suggesting that in vitro functional study will provide more information for the diagnosis of the patients with suspected LQTS.
出处 《中国心脏起搏与心电生理杂志》 2014年第4期300-303,共4页 Chinese Journal of Cardiac Pacing and Electrophysiology
基金 国家重点基础研究发展计划项目(973计划 编号2013CB531105) 国家自然科学基金项目(项目编号:81370292 81370290)
关键词 心血管病学 长QT综合征 基因变异 膜片钳 Cardiology Long QT syndrome Gene variant Patch clamp
  • 相关文献

参考文献8

  • 1Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromesexpert consensus state- ment on inherited primary arrhythmia syndromes: Document en- dorsed by HRS, EHRA, and APHRS in may 2013 and by ACCF, AHA, PACES, and AEPC in june 2013 [ J]. Heart Rhythm, 2013 : e75.
  • 2Ackerman M J, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelop- athies and cardiomyopathies this document was developed as a part- nership between the heart rhythm society (HRS) and the european heart rhythm association (EHRA) [J]. Heart Rhythm, 2011, 8 (8) :1 308.
  • 3Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long- qt syndrome: Clinical impact [J]. Circulation, 1999, 99 (4) :529.
  • 4Ruan Y, Liu N, Bloise R, et al. Gating properties of SCN5A muta- tions and the response to mexiletine in long-QT syndrome type 3 pa- tients [J]. Circulation, 2007, 116 (10):1 137.
  • 5Napolitano C, Priori SG, Schwartz PJ, et al. Genetic testing in the long QT syndrome: Development and validation of an efficient ap- proach to genotyping in clinical practice [ J ]. JAMA, 2005, 294 (23) :2 975.
  • 6Kapa S, Tester DJ, Salisbury BA, et al. Genetic testing for long-QT syndrome: Distinguishing pathogenic mutations from benign variants [J]. Circulation, 2009, 120 (18) :1 752.
  • 7Giudicessi JR, Ackerman MJ. Genetic testing in heritable cardiac ar- rhythmia syndromes: Differentiating pathogenic mutations from back- ground genetic noise [J]. Curr Opin Cardiol, 2013, 28 (1) :63.
  • 8Faye LL, Machiela M J, Kraft P, et al. Re-ranking sequencing vari- ants in the post-gwas era for accurate causal variant identification [J]. PLoS Genet, 2013, 9 (8) :e1003 609.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部